Foghorn Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Foghorn Therapeutics (FHTX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Foghorn Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Foghorn Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Foghorn Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $103k | 19k | 5.40 |
| 2025-09-30 | $104k | 21k | 4.89 |
| 2025-06-30 | $102k | 22k | 4.70 |
| 2024-09-30 | $148k | 16k | 9.31 |
| 2024-06-30 | $40k | 6.9k | 5.75 |
| 2023-09-30 | $57k | 11k | 5.00 |
| 2023-06-30 | $81k | 11k | 7.04 |
| 2022-12-31 | $87k | 14k | 6.38 |
| 2022-09-30 | $117k | 14k | 8.58 |
| 2022-06-30 | $185k | 14k | 13.60 |
| 2022-03-31 | $208k | 14k | 15.26 |
| 2021-12-31 | $199k | 8.7k | 22.92 |
| 2021-09-30 | $121k | 8.7k | 13.93 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors